Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, No. 188, Shizi Street, Suzhou, 215006, China.
Cardiovasc Intervent Radiol. 2021 Oct;44(10):1597-1608. doi: 10.1007/s00270-021-02907-0. Epub 2021 Jul 8.
Based on an artificial intelligence approach, this study attempted to establish prognostic models to predict 3-month overt hepatic encephalopathy (OHE) occurrence, 1-year mortality, and liver dysfunction for cirrhotic patients with acute variceal bleeding (AVB) treated with early transjugular intrahepatic portosystemic shunt (TIPS) creation.
This retrospective study included patients treated with early TIPS between January 2016 and November 2019. Independent risk factors associated with occurrence of OHE within 3 months, 1-year mortality, and liver dysfunction after early TIPS were identified using univariate and multivariate logistic analyses. Artificial neural network (ANN) models and prognostic nomograms based on the independent risk factors were established and validated internally.
A total of 207 patients were included, with 33 (15.9%) experienced OHE within 3 months after TIPS creation. The albumin-bilirubin grade (P = 0.015), age (≤ 65, > 65 years) (P < 0.001), gender (P = 0.002), and alcoholic cirrhosis (P = 0.013) was identified as independent risk factors associated with 3-month OHE. Presence of portal vein thrombosis (P = 0.034) and model for end-stage liver disease score (P = 0.063) were identified as independent risk factors associated with 1-year mortality. The platelet-albumin-bilirubin grade (P = 0.041) and a history of hepatic encephalopathy (P = 0.018) were identified as independent risk factors associated with liver dysfunction after TIPS creation. Three ANN models and three nomograms were then established and validated with high accuracy.
The ANN and nomogram models have potential to accurately predict early occurrence of OHE, mortality, and liver dysfunction after early TIPS creation for cirrhotic patients with AVB.
基于人工智能方法,本研究试图建立预测模型,以预测接受早期经颈静脉肝内门体分流术(TIPS)治疗的肝硬化急性静脉曲张出血(AVB)患者发生 3 个月显性肝性脑病(OHE)、1 年死亡率和肝功能障碍的风险。
本回顾性研究纳入了 2016 年 1 月至 2019 年 11 月期间接受早期 TIPS 治疗的患者。使用单因素和多因素逻辑分析确定与 3 个月内发生 OHE、1 年死亡率和早期 TIPS 后肝功能障碍相关的独立危险因素。建立并内部验证基于独立危险因素的人工神经网络(ANN)模型和预测列线图。
共纳入 207 例患者,其中 33 例(15.9%)在 TIPS 治疗后 3 个月内发生 OHE。白蛋白-胆红素分级(P=0.015)、年龄(≤65 岁,>65 岁)(P<0.001)、性别(P=0.002)和酒精性肝硬化(P=0.013)是与 3 个月 OHE 相关的独立危险因素。门静脉血栓形成(P=0.034)和终末期肝病模型评分(P=0.063)是与 1 年死亡率相关的独立危险因素。血小板-白蛋白-胆红素分级(P=0.041)和肝性脑病史(P=0.018)是与 TIPS 治疗后肝功能障碍相关的独立危险因素。然后建立并验证了三个 ANN 模型和三个列线图,具有较高的准确性。
ANN 和列线图模型有可能准确预测肝硬化急性静脉曲张出血患者接受早期 TIPS 治疗后早期发生 OHE、死亡率和肝功能障碍的风险。